207 related articles for article (PubMed ID: 17855736)
1. Cardiac surgery with cardiopulmonary bypass: does aprotinin affect outcome?
Van der Linden PJ; Hardy JF; Daper A; Trenchant A; De Hert SG
Br J Anaesth; 2007 Nov; 99(5):646-52. PubMed ID: 17855736
[TBL] [Abstract][Full Text] [Related]
2. Does the combination of aprotinin and angiotensin-converting enzyme inhibitor cause renal failure after cardiac surgery?
Kincaid EH; Ashburn DA; Hoyle JR; Reichert MG; Hammon JW; Kon ND
Ann Thorac Surg; 2005 Oct; 80(4):1388-93; discussion 1393. PubMed ID: 16181876
[TBL] [Abstract][Full Text] [Related]
3. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.
Maslow AD; Chaudrey A; Bert A; Schwartz C; Singh A
J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):6-15. PubMed ID: 18249324
[TBL] [Abstract][Full Text] [Related]
4. Aprotinin is safe in pediatric patients undergoing cardiac surgery.
Backer CL; Kelle AM; Stewart RD; Suresh SC; Ali FN; Cohn RA; Seshadri R; Mavroudis C
J Thorac Cardiovasc Surg; 2007 Dec; 134(6):1421-6; discussion 1426-8. PubMed ID: 18023656
[TBL] [Abstract][Full Text] [Related]
5. Coronary artery bypass grafting after aprotinin: are we doing better?
Beckerman Z; Shopen Y; Alon H; Cohen O; Nir RR; Adler Z; Bolotin G
J Thorac Cardiovasc Surg; 2013 Jan; 145(1):243-8. PubMed ID: 23072702
[TBL] [Abstract][Full Text] [Related]
6. A comparison before and after aprotinin was suspended in cardiac surgery: different results in the real world from a single cardiac center in China.
Wang X; Zheng Z; Ao H; Zhang S; Wang Y; Zhang H; Li L; Hu S
J Thorac Cardiovasc Surg; 2009 Oct; 138(4):897-903. PubMed ID: 19660368
[TBL] [Abstract][Full Text] [Related]
7. Retrospective cohort analysis of a single dose of aprotinin use in children undergoing cardiac surgery: a single-center experience.
Fan Y; Lin R; Yang L; Ye L; Yu J; Shu Q
Paediatr Anaesth; 2013 Mar; 23(3):242-9. PubMed ID: 23189963
[TBL] [Abstract][Full Text] [Related]
8. The risk associated with aprotinin in cardiac surgery.
Mangano DT; Tudor IC; Dietzel C; ;
N Engl J Med; 2006 Jan; 354(4):353-65. PubMed ID: 16436767
[TBL] [Abstract][Full Text] [Related]
9. The critical role of aprotinin in controlling haemostasis in conjunction with non-pharmacological blood-saving strategies during routine coronary artery bypass surgery.
Khalil PN; Siebeck M; Ismail M; Khalil MN; von Knobelsdorff G; Marx G; Kalmar P
Eur J Med Res; 2006 Sep; 11(9):386-93. PubMed ID: 17101462
[TBL] [Abstract][Full Text] [Related]
10. Con: Aprotinin should not be used in cardiac surgery with cardiopulmonary bypass.
Augoustides JG
J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):302-4. PubMed ID: 17418754
[No Abstract] [Full Text] [Related]
11. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
12. The impact of aprotinin on postoperative renal dysfunction in neonates undergoing cardiopulmonary bypass: a retrospective analysis.
Guzzetta NA; Evans FM; Rosenberg ES; Fazlollah TM; Baker MJ; Wilson EC; Kaiser AM; Tosone SR; Miller BE
Anesth Analg; 2009 Feb; 108(2):448-55. PubMed ID: 19151271
[TBL] [Abstract][Full Text] [Related]
13. Aprotinin and perioperative complications in cardiac surgery.
Kertai MD; Varga KS; Royston D; London MJ; Szabolcs Z; Grebenik CR; Acsady G; Gal J
J Cardiovasc Surg (Torino); 2007 Dec; 48(6):761-72. PubMed ID: 17947935
[TBL] [Abstract][Full Text] [Related]
14. Aprotinin in cardiac surgery patients: is the risk worth the benefit?
Stamou SC; Reames MK; Skipper E; Stiegel RM; Nussbaum M; Geller R; Robicsek F; Lobdell KW
Eur J Cardiothorac Surg; 2009 Nov; 36(5):869-75. PubMed ID: 19782574
[TBL] [Abstract][Full Text] [Related]
15. The risks associated with aprotinin use: a retrospective study of cardiac cases in Nova Scotia.
Riddell RE; Buth KJ; Sullivan JA
Can J Anaesth; 2013 Jan; 60(1):16-23. PubMed ID: 23132043
[TBL] [Abstract][Full Text] [Related]
16. The effect of antifibrinolytic prophylaxis on postoperative outcomes in patients undergoing cardiac operations.
Koul A; Ferraris V; Davenport DL; Ramaiah C
Int Surg; 2012; 97(1):34-42. PubMed ID: 23101999
[TBL] [Abstract][Full Text] [Related]
17. [Hemostatic management for cardiac surgical patients in the post-aprotinin era].
Tanaka K
Masui; 2009 Mar; 58(3):288-97. PubMed ID: 19306629
[TBL] [Abstract][Full Text] [Related]
18. Effect of aprotinin on renal dysfunction in patients undergoing on-pump and off-pump cardiac surgery: a retrospective observational study.
Mouton R; Finch D; Davies I; Binks A; Zacharowski K
Lancet; 2008 Feb; 371(9611):475-82. PubMed ID: 18262039
[TBL] [Abstract][Full Text] [Related]
19. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O
J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414
[TBL] [Abstract][Full Text] [Related]
20. The association of renal dysfunction and the use of aprotinin in patients undergoing congenital cardiac surgery requiring cardiopulmonary bypass.
Manrique A; Jooste EH; Kuch BA; Lichtenstein SE; Morell V; Munoz R; Ellis D; Davis PJ
Anesth Analg; 2009 Jul; 109(1):45-52. PubMed ID: 19535694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
